These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 741921)

  • 1. [Relationship between the manifestation of diabetes and the treatment of hyperlipemia].
    Vogelberg KH
    Verh Dtsch Ges Inn Med; 1978; (84):1178-81. PubMed ID: 741921
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
    Gatti A; Carletta C
    Clin Ter; 1979 Oct; 91(1):57-65. PubMed ID: 397871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clofibrate in the treatment of diabetes mellitus].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):359-62. PubMed ID: 30153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate].
    Bruns W; Rjasanowski I; Wulfert P; Michael R; Knospe S; Hildmann W
    Endokrinologie; 1974 Nov; 64(1):2-12. PubMed ID: 4466653
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of oxandrolone, protein anabolic steroid, on hyperlipemia: comparison between cases of hyperlipemia with or without diabetes].
    Okuno G
    Naika; 1972; 29(2):330-4. PubMed ID: 5015105
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A
    Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate].
    Nicrosini F; Pasotti C
    Clin Ter; 1979 Aug; 90(3):241-50. PubMed ID: 553752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
    Singer P; Gnauck G; Honigmann G; Thoelke H; Schliack V; Läuter J
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):27-37. PubMed ID: 913315
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is primary or secondary prevention of diabetes mellitus in hyperliporoteinemia possible under long-term clofibrate therapy?].
    Haller H; Michaelis D; Hanefeld M; Leonhardt W; Schulze J
    Z Gesamte Inn Med; 1976 Jul; 31(13):481-5. PubMed ID: 822610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and treatment of risk factors in chronic ischemic heart disease].
    Neugebauer A; Trenckmann H; Duck HJ; Fleischmann HJ; Schauer J
    Z Gesamte Inn Med; 1974 Oct; 29(19):809-14. PubMed ID: 4460433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
    Janka HU; Standl A; Holler HD; Mehnert H
    MMW Munch Med Wochenschr; 1982 May; 124(21):535-7. PubMed ID: 6810123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperlipemia and pancreatitis].
    Carrillo Penso N; Carrasquero O; Medina JA
    G E N; 1981; 35(1-2):15-27. PubMed ID: 6816659
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypolipidemic treatment in renal insufficiency].
    Synková J; Groh J; Brátová M; Zahradník J; Jánská D
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(3):385-90. PubMed ID: 6977836
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of drugs affecting lipids on atherosclerosis.
    Ditschuneit H
    Horm Metab Res; 1974; Suppl 4():191-4. PubMed ID: 4421312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and pathophysiological aspects of diabetic and familial hyperlipemia].
    Izumi K; Otoshi M; Hashimoto T; Takamiya O
    Iryo; 1970 Sep; 24(9):693-8. PubMed ID: 5474224
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
    Mertz DP; Sulzberger I; Klöpfer M
    Munch Med Wochenschr; 1970 Feb; 112(6):241-7. PubMed ID: 5537894
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the hyperlipoproteinemias in diabetes mellitus].
    Mincou I; Ionesco-Tirgoviste C; Cheta D; Georgesco M
    Journ Annu Diabetol Hotel Dieu; 1977; ():210-27. PubMed ID: 894865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of clofibrate on unsaturated fatty acids in lipid fractions of sera in patients with hyperlipemia].
    Felt V; Husek P
    Vnitr Lek; 1976 Mar; 22(3):256-61. PubMed ID: 1266086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.